171 related articles for article (PubMed ID: 31684176)
41. PI3K inhibitor enhances the cytotoxic response to etoposide and cisplatin in a newly established neuroendocrine cervical carcinoma cell line.
Lai ZY; Yeo HY; Chen YT; Chang KM; Chen TC; Chuang YJ; Chang SJ
Oncotarget; 2017 Jul; 8(28):45323-45334. PubMed ID: 28484083
[TBL] [Abstract][Full Text] [Related]
42. Growth inhibitory and adjuvant therapeutic potential of aqueous extract of Triticum aestivum on MCF-7 and HeLa cells.
Hussain A; Gheewala TM; Vas AJ; Shah K; Goala P; Khan S; Hinduja S; Sharma C
Exp Oncol; 2014 Mar; 36(1):9-16. PubMed ID: 24691278
[TBL] [Abstract][Full Text] [Related]
43. Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer.
Wang T; Liu Z; Shi F; Wang J
Mol Cell Biochem; 2016 Feb; 413(1-2):179-87. PubMed ID: 26820938
[TBL] [Abstract][Full Text] [Related]
44. Synergistic effects of ICI 182,780 on the cytotoxicity of cisplatin in cervical carcinoma cell lines.
García-López P; Rodríguez-Dorantes M; Pérez-Cárdenas E; Cerbón M; Mohar-Betancourt A
Cancer Chemother Pharmacol; 2004 Jun; 53(6):533-40. PubMed ID: 15138713
[TBL] [Abstract][Full Text] [Related]
45. Melatonin sensitizes human cervical cancer HeLa cells to cisplatin-induced cytotoxicity and apoptosis: effects on oxidative stress and DNA fragmentation.
Pariente R; Pariente JA; Rodríguez AB; Espino J
J Pineal Res; 2016 Jan; 60(1):55-64. PubMed ID: 26462739
[TBL] [Abstract][Full Text] [Related]
46. Vitamin C in synergism with cisplatin induces cell death in cervical cancer cells through altered redox cycling and p53 upregulation.
Leekha A; Gurjar BS; Tyagi A; Rizvi MA; Verma AK
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2503-2514. PubMed ID: 27613187
[TBL] [Abstract][Full Text] [Related]
47. Eugenol potentiates cisplatin anti-cancer activity through inhibition of ALDH-positive breast cancer stem cells and the NF-κB signaling pathway.
Islam SS; Al-Sharif I; Sultan A; Al-Mazrou A; Remmal A; Aboussekhra A
Mol Carcinog; 2018 Mar; 57(3):333-346. PubMed ID: 29073729
[TBL] [Abstract][Full Text] [Related]
48. Apoptosis of HeLa cells induced by cisplatin and its mechanism.
Liu Y; Xing H; Han X; Shi X; Liang F; Cheng G; Lu Y; Ma D
J Huazhong Univ Sci Technolog Med Sci; 2008 Apr; 28(2):197-9. PubMed ID: 18480997
[TBL] [Abstract][Full Text] [Related]
49. Formononetin potentiates epirubicin-induced apoptosis via ROS production in HeLa cells in vitro.
Lo YL; Wang W
Chem Biol Interact; 2013 Oct; 205(3):188-97. PubMed ID: 23867903
[TBL] [Abstract][Full Text] [Related]
50. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S
Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130
[TBL] [Abstract][Full Text] [Related]
51. Enhancement of lexatumumab-induced apoptosis in human solid cancer cells by Cisplatin in caspase-dependent manner.
Wu XX; Kakehi Y
Clin Cancer Res; 2009 Mar; 15(6):2039-47. PubMed ID: 19276256
[TBL] [Abstract][Full Text] [Related]
52. Dehydrobruceine B enhances the cisplatin-induced cytotoxicity through regulation of the mitochondrial apoptotic pathway in lung cancer A549 cells.
Huang Z; Yang G; Shen T; Wang X; Li H; Ren D
Biomed Pharmacother; 2017 May; 89():623-631. PubMed ID: 28262615
[TBL] [Abstract][Full Text] [Related]
53. Knockdown of ST6Gal-I increases cisplatin sensitivity in cervical cancer cells.
Zhang X; Pan C; Zhou L; Cai Z; Zhao S; Yu D
BMC Cancer; 2016 Dec; 16(1):949. PubMed ID: 27986075
[TBL] [Abstract][Full Text] [Related]
54. Induction of apoptosis by eugenol in human breast cancer cells.
Vidhya N; Devaraj SN
Indian J Exp Biol; 2011 Nov; 49(11):871-8. PubMed ID: 22126019
[TBL] [Abstract][Full Text] [Related]
55. Combination of 2-methoxyestradiol (2-ME2) and eugenol for apoptosis induction synergistically in androgen independent prostate cancer cells.
Ghosh R; Ganapathy M; Alworth WL; Chan DC; Kumar AP
J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):25-35. PubMed ID: 19084597
[TBL] [Abstract][Full Text] [Related]
56. Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer.
Casagrande N; De Paoli M; Celegato M; Borghese C; Mongiat M; Colombatti A; Aldinucci D
Gynecol Oncol; 2013 Dec; 131(3):744-52. PubMed ID: 24029417
[TBL] [Abstract][Full Text] [Related]
57. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
Alas S; Ng CP; Bonavida B
Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
[TBL] [Abstract][Full Text] [Related]
58. Propofol enhances the cisplatin-induced apoptosis on cervical cancer cells via EGFR/JAK2/STAT3 pathway.
Li H; Lu Y; Pang Y; Li M; Cheng X; Chen J
Biomed Pharmacother; 2017 Feb; 86():324-333. PubMed ID: 28011380
[TBL] [Abstract][Full Text] [Related]
59. Analysis of the in vitro synergistic effect of 5-fluorouracil and cisplatin on cervical carcinoma cells.
Yim EK; Lee SB; Lee KH; Kim CJ; Park JS
Int J Gynecol Cancer; 2006; 16(3):1321-9. PubMed ID: 16803524
[TBL] [Abstract][Full Text] [Related]
60. Synergistic antitumor effect of ginsenoside Rg3 and cisplatin in cisplatin‑resistant bladder tumor cell line.
Lee YJ; Lee S; Ho JN; Byun SS; Hong SK; Lee SE; Lee E
Oncol Rep; 2014 Nov; 32(5):1803-8. PubMed ID: 25175462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
